Pancreatic Exocrine Insufficiency
📧 Sign up to get email alerts when something new happens for Pancreatic Exocrine Insufficiency.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: IPEX Study: Pancreatic Exocrine Insufficiency as a Functional Marker of Disease Progression in Patients With IPMN
This clinical trial update describes the IPEX study, which investigates pancreatic exocrine insufficiency as a functional marker of disease …
-
CLINICAL_TRIALS other · 2026-03-02Clinical Trial Update: Pancreatic Enzyme Replacement in Acute Necrotizing Pancreatitis [Phase 3]
A Phase 3 clinical trial assessing pancreatic enzyme replacement for acute necrotizing pancreatitis and pancreatic exocrine insufficiency is…
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: A Study on the Changes of Glucose Metabolism and Exocrine Function in Patients With Chronic Pancreatitis [EARLY_Phase 1]
A Phase 1 clinical trial at Shanghai Changzheng Hospital evaluating changes in glucose metabolism and exocrine pancreatic function in patien…
-
CLINICAL_TRIALS research · 2025-04-27Clinical Trial Update: Investigation on the Current Situation and Risk Factors Analysis of Exocrine Insufficiency in Chronic Pancreatitis
A completed clinical trial evaluating the current status and risk factors for pancreatic exocrine insufficiency in chronic pancreatitis.
-
CLINICAL_TRIALS trial_result · 2025-04-10Clinical Trial Update: Medication Adherence to Phone-supervised Pancreatic Enzyme Replacement Therapy [NA]
A clinical trial update describes medication adherence to a phone-supervised pancreatic enzyme replacement therapy protocol for patients wit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-12-24Clinical Trial Update: PERT to Improve Quality of Life in Patients Undergoing Pancreaticoduodenectomy: A Pilot Randomized Controlled Trial [NA]
A pilot randomized controlled trial is evaluating whether pancreatic enzyme replacement therapy improves quality of life for patients with p…
-
CLINICAL_TRIALS trial_result · 2024-07-16Clinical Trial Update: Post Acute Pancreatitis Pancreatic Exocrine Insufficiency
A clinical trial investigating post-acute pancreatitis pancreatic exocrine insufficiency has completed the study.
-
CLINICAL_TRIALS trial_result · 2024-04-30Clinical Trial Update: Proton Pump Inhibitors (PPI) and Fat Absorption in Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (EPI) [Phase 2]
Phase 2 trial evaluating the effect of proton pump inhibitors on fat absorption in cystic fibrosis with pancreatic exocrine insufficiency. T…
-
FDA approval · 2024-02-28FDA Approved: PERTZYE — Supplemental Application (Digestive Care, Inc.)
FDA approved a supplemental application for PERTZYE (pancrelipase) submitted by Digestive Care, Inc.
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: The Effect of PERT on Patients Undergoing Pancreaticoduodenectomy [Phase 4]
Phase 4 trial update assessing the effect of pancreatic enzyme replacement therapy in patients undergoing pancreaticoduodenectomy.
-
FDA approval · 2022-10-21FDA Approved: VIOKACE — Supplemental Application (Aimmune Therapeutics, Inc.)
The FDA approved a supplemental application for Viokace (pancrelipase) by Aimmune Therapeutics, Inc.
-
CLINICAL_TRIALS trial_result · 2022-06-10Clinical Trial Update: Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis
Clinical trial update for LipaCreon in pancreatic exocrine insufficiency due to cystic fibrosis has completed; results posted.
-
FDA label_change · 2020-01-28FDA Approved: PANCREAZE — Supplemental Application (VIVUS LLC)
FDA approved a supplemental application for Pancreaze (pancrelipase enzyme mix) from VIVUS LLC.
-
CLINICAL_TRIALS trial_result · 2015-11-27Clinical Trial Update: A Double-blind, Randomized, Multicenter, Cross-over Study to Compare the Effect of Creon N and Creon® on Fat Digestion in Subjects ≥ 12 Years of Age With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis [Phase 3]
A Phase 3 double-blind, randomized, cross-over trial comparing Creon N to Creon in subjects aged 12 or older with pancreatic exocrine insuff…
-
CLINICAL_TRIALS trial_result · 2014-07-15Clinical Trial Update: Evaluation of Safety and Tolerability of Creon Micro in Children Younger Than Four Years With Pancreatic Exocrine Insufficiency [Phase 3]
This Phase 3 trial assessed the safety and tolerability of Creon Micro in children under four with pancreatic exocrine insufficiency; result…
-
CLINICAL_TRIALS withdrawal · 2012-07-02Clinical Trial Update: Comparison of Secretin-enhanced Magnetic Resonance Cholangiopancreatography (S-MRCP) to Endoscopic Pancreatic Function Test (ePFT) in Diagnosing Pancreatic Exocrine Insufficiency [NA]
This clinical trial comparing Secretin-enhanced MRCP with Endoscopic Pancreatic Function Test for diagnosing pancreatic exocrine insufficien…
-
CLINICAL_TRIALS research · 2011-08-18Clinical Trial Update: Creon 40,000 for Treatment of PEI (Pancreatic Exocrine Insufficiency) Due to Chronic Pancreatitis [Phase 3]
A Phase 3 trial evaluating Creon 40,000 (pancrelipase) for pancreatic exocrine insufficiency due to chronic pancreatitis has completed.
-
CLINICAL_TRIALS trial_result · 2011-08-01Clinical Trial Update: A Open-label Study to Assess the Safety of Oral Long-term Use of SA-001 in Pancreatic Exocrine Insufficiency [Phase 3]
Phase 3 open-label safety trial of SA-001 in pancreatic exocrine insufficiency has completed, assessing long-term oral safety. The study inc…
-
CLINICAL_TRIALS trial_result · 2010-10-01Clinical Trial Update: Study Investigating a Delayed-Release Pancrelipase in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis [Phase 3]
Phase 3 results update on a delayed-release pancrelipase for pancreatic exocrine insufficiency in cystic fibrosis; the study has completed a…
-
CLINICAL_TRIALS trial_result · 2010-03-10Clinical Trial Update: Study Investigating a Delayed-Release Pancrelipase in Patients With Pancreatic Exocrine Insufficiency (PEI) Due to Cystic Fibrosis (CF) [Phase 3]
Phase 3 study evaluating a delayed-release pancrelipase in pancreatic exocrine insufficiency due to cystic fibrosis has completed, with resu…
-
CLINICAL_TRIALS trial_result · 2009-09-16Clinical Trial Update: A Study to Investigate the Effect of Delayed Release Pancrelipase on Maldigestion in Patients With Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis and Pancreatectomy [Phase 3]
Phase 3 trial evaluating delayed-release pancrelipase for maldigestion in patients with exocrine pancreatic insufficiency due to chronic pan…